Tokyo Tape
Sign in
← Nissha

Quarterly report · Q3

7915.TEDINET S100S58I
Period2023-01-01 → 2023-09-30
Filed2023-11-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 50
MetricValuePeriodScopeSource row
Operating income−¥414m2023-01-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income−¥472m2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income¥9.7bn2022-01-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥3.4bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax¥998m2023-01-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥88m2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax¥12.4bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥13.9bn2022-01-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥4.4bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥575m2023-01-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥225m2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥10.1bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥11.8bn2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.9bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥555m2023-01-01 → 2023-09-30Cons.Profit loss IFRS
Net income−¥230m2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income¥11.8bn2022-01-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥3.9bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥228.0bnat 2023-09-30Cons.Assets IFRS
Total assets¥230.2bnat 2022-12-31Cons.Assets IFRS
Total assets¥239.3bnat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥111.9bnat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥118.7bnat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥116.1bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥111.5bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥116.6bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥98.3bnat 2021-12-31dCons.Equity IFRS
Equity (owners)¥116.1bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥111.6bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥116.7bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥44.8bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥54.3bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥52.5bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Operating cash flow−¥676m2023-01-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥12.0bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥7.9bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥4.9bn2023-01-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥4.4bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥5.1bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥7.0bn2023-01-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥1.1bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥2.6bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥11.762023-01-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-4.622023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥203.652022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥237.142022-01-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥78.522022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
Equity ratio50.9%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.5%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.8%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-09-30−¥648m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-07-01 → 2023-09-30−¥192m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-09-30−¥1.5bn
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-09-30−¥695m
jpcrp040300-q3r_E00703-000Devicesreportable segmentsegment profit2023-01-01 → 2023-09-30−¥1.5bn
jpcrp040300-q3r_E00703-000Devicesreportable segmentsegment profit2023-07-01 → 2023-09-30−¥323m
jpcrp040300-q3r_E00703-000Industrial Materialsreportable segmentsegment profit2023-01-01 → 2023-09-30¥1.9bn
jpcrp040300-q3r_E00703-000Industrial Materialsreportable segmentsegment profit2023-07-01 → 2023-09-30¥458m
jpcrp040300-q3r_E00703-000Medical Technologiesreportable segmentsegment profit2023-01-01 → 2023-09-30¥1.3bn
jpcrp040300-q3r_E00703-000Medical Technologiesreportable segmentsegment profit2023-07-01 → 2023-09-30¥280m
—segment totalsegment profit2023-01-01 → 2023-09-30¥1.7bn
—segment totalsegment profit2023-07-01 → 2023-09-30¥414m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-09-30¥1.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-07-01 → 2023-09-30¥222m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-09-30−¥560m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-07-01 → 2022-09-30−¥151m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-09-30−¥979m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥578m
jpcrp040300-q3r_E00703-000Devicesreportable segmentsegment profit2022-01-01 → 2022-09-30¥6.5bn
jpcrp040300-q3r_E00703-000Devicesreportable segmentsegment profit2022-07-01 → 2022-09-30¥2.9bn
jpcrp040300-q3r_E00703-000Industrial Materialsreportable segmentsegment profit2022-01-01 → 2022-09-30¥4.5bn
jpcrp040300-q3r_E00703-000Industrial Materialsreportable segmentsegment profit2022-07-01 → 2022-09-30¥1.1bn
jpcrp040300-q3r_E00703-000Medical Technologiesreportable segmentsegment profit2022-01-01 → 2022-09-30¥151m
jpcrp040300-q3r_E00703-000Medical Technologiesreportable segmentsegment profit2022-07-01 → 2022-09-30¥150m
—segment totalsegment profit2022-01-01 → 2022-09-30¥11.2bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥4.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-09-30¥10.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-07-01 → 2022-09-30¥4.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 898
ItemContextValueUnit
Sales to external customers IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember16983000000JPY
Sales to external customers IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember13146000000JPY
Sales to external customers IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember8937000000JPY
Sales to external customers IFRSCurrentQuarterDuration_ReportableSegmentsMember39067000000JPY
Sales to external customers IFRSCurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1812000000JPY
Sales to external customers IFRSCurrentQuarterDuration_TotalOfReportableSegmentsAndOthersMember40879000000JPY
Sales to external customers IFRSCurrentQuarterDuration_ReconcilingItemsMember－JPY
Sales to external customers IFRSCurrentQuarterDuration40879000000JPY
Intersegment sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember44000000JPY
Intersegment sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember2000000JPY
Intersegment sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember－JPY
Intersegment sales IFRSCurrentQuarterDuration_ReportableSegmentsMember47000000JPY
Intersegment sales IFRSCurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember211000000JPY
Intersegment sales IFRSCurrentQuarterDuration_TotalOfReportableSegmentsAndOthersMember259000000JPY
Intersegment sales IFRSCurrentQuarterDuration_ReconcilingItemsMember-259000000JPY
Intersegment sales IFRSCurrentQuarterDuration－JPY
Net sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember17028000000JPY
Net sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember13148000000JPY
Net sales IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember8937000000JPY
Net sales IFRSCurrentQuarterDuration_ReportableSegmentsMember39115000000JPY
Net sales IFRSCurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember2024000000JPY
Net sales IFRSCurrentQuarterDuration_TotalOfReportableSegmentsAndOthersMember41139000000JPY
Net sales IFRSCurrentQuarterDuration_ReconcilingItemsMember-259000000JPY
Net sales IFRSCurrentQuarterDuration40879000000JPY
Operating profit loss IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember458000000JPY
Operating profit loss IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember-323000000JPY
Operating profit loss IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember280000000JPY
Operating profit loss IFRSCurrentQuarterDuration_ReportableSegmentsMember414000000JPY
Operating profit loss IFRSCurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-192000000JPY
Operating profit loss IFRSCurrentQuarterDuration_TotalOfReportableSegmentsAndOthersMember222000000JPY
Operating profit loss IFRSCurrentQuarterDuration_ReconcilingItemsMember-695000000JPY
Operating profit loss IFRSCurrentQuarterDuration-472000000JPY
Finance income IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember－JPY
Finance income IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember－JPY
Finance income IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember－JPY
Finance income IFRSCurrentQuarterDuration_ReportableSegmentsMember－JPY
Finance income IFRSCurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Finance income IFRSCurrentQuarterDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Finance income IFRSCurrentQuarterDuration_ReconcilingItemsMember－JPY
Finance income IFRSCurrentQuarterDuration937000000JPY
Finance costs IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember－JPY
Finance costs IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember－JPY
Finance costs IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000MedicalTechnologiesReportableSegmentMember－JPY
Finance costs IFRSCurrentQuarterDuration_ReportableSegmentsMember－JPY
Finance costs IFRSCurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Finance costs IFRSCurrentQuarterDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Finance costs IFRSCurrentQuarterDuration_ReconcilingItemsMember－JPY
Finance costs IFRSCurrentQuarterDuration553000000JPY
Profit loss before tax IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000IndustrialMaterialsReportableSegmentMember－JPY
Profit loss before tax IFRSCurrentQuarterDuration_jpcrp040300-q3r_E00703-000DevicesReportableSegmentMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass